FDA Approves TRUVADA For Teens At Risk

Gilead Sciences, Inc. announced this week that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Truvada® —in combination with safer sex practices—to reduce the risk of sexually acquired HIV-1 in at-risk adolescents. The addition of the adolescent Read more